MARIA DEL MAR
ESTEBAN ORTEGA
PROFESOR
Publicacions (37) Publicacions de MARIA DEL MAR ESTEBAN ORTEGA
2024
-
An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis
Journal of Clinical Medicine, Vol. 13, Núm. 5
-
Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings
Ocular Immunology and Inflammation
-
Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©
Ophthalmology and Therapy
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
AB1470 Janus Kinase Inhibitors in Severe Inflammatory Ocular Pathology. Multicenter Study and Literature Review
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1963.2-1964
-
Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)
Ophthalmology and Therapy
-
POS0652 Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: Uvedai
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 604-605
-
POS0793-HPR Observational Study in Real Clinical Practice of the Treatment of Non-Infectious Uveitis
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 689.2-690
-
Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055
2022
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
-
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Clinical and Experimental Rheumatology
-
Ocular inflammatory events following COVID-19 vaccination: a multinational case series
Journal of Ophthalmic Inflammation and Infection, Vol. 12, Núm. 1
2021
-
AB0396 Rapid Improvement in Cystoid Macular Edema With High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis ff Different Immune Mediated Inflammatory Diseases
Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1225.3-1226
-
AB0771 High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases
Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1412.1-1412
-
Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid
Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2
-
Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis
Ocular Immunology and Inflammation, Vol. 29, Núm. 2, pp. 376-387
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
2020
-
AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis
Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Reproducibilidad de la medición manual del grosor coroideo utilizando la tomografía de coherencia óptica
Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 8, pp. 379-385